<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Vioxx News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/vioxx/</link>
		<description>Vioxx News. Read about side effects of Vioxx, Bextra and Celebrex. Read the latest medical and scientific information on Vioxx and the link between certain medications and heart attacks.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 23:07:35 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 23:07:35 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Vioxx News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/vioxx/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/vioxx" /><feedburner:info uri="sciencedaily/health_medicine/vioxx" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/vioxx</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>Study quells concerns about NAID safety</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/q5Ae5wdayL8/150831085459.htm</link>
			<description>In older patients with arthritis and no history of cardiovascular disease, chronic use of any non-steroidal anti-inflammatory drug appears safe from a cardiovascular and gastrointestinal stand-point, and regular, non-selective NSAIDs such as ibuprofen and diclofenac appear just as safe as the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib according to results the SCOT trial.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/q5Ae5wdayL8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 31 Aug 2015 08:54:59 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150831085459.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150831085459.htm</feedburner:origLink></item>
		<item>
			<title>Biomarker discovery sheds new light on heart attack risk of arthritis drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/Xxj0D1gTnaY/141210114212.htm</link>
			<description>A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it. A new study sheds light on the 10-year-old question of how COX-2 inhibitors -- a type of non-steroidal anti-inflammatory drug (NSAID) -- can increase the risk of heart attack in some people.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/Xxj0D1gTnaY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 10 Dec 2014 11:42:12 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/12/141210114212.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/12/141210114212.htm</feedburner:origLink></item>
		<item>
			<title>More evidence arthritis/pain relieving drugs may contribute to stroke death</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/DNJhXpGvGc8/141105165053.htm</link>
			<description>Commonly prescribed, older drugs for arthritis and pain may increase the risk of death from stroke, according to a study. "Our study supports stepping up efforts to make sure people with a higher risk of stroke are not prescribed these medications when other options are available," authors concluded.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/DNJhXpGvGc8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 05 Nov 2014 16:50:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/11/141105165053.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/11/141105165053.htm</feedburner:origLink></item>
		<item>
			<title>Common painkillers combined with other drugs may cause high risk of GI bleeding</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/R9QFuVogDV8/141002101214.htm</link>
			<description>Nonsteroidal anti-inflammatory drugs -- such as ibuprofen and aspirin -- increase one's risk of upper gastrointestinal bleeding. When taken in combination with other drugs, this risk is significantly higher, according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/R9QFuVogDV8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 02 Oct 2014 10:12:14 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/10/141002101214.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/10/141002101214.htm</feedburner:origLink></item>
		<item>
			<title>Safer alternatives to nonsteroidal antinflamatory pain killers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/j41DL0TBLr4/140421151834.htm</link>
			<description>Building on previous work that showed that deleting an enzyme in the COX-2 pathway in a mouse model of heart disease slowed the development of atherosclerosis, researchers have now extended this observation by clarifying that the consequence of deleting the enzyme mPEGS-1 differs, depending on the cell type in which it is taken away. They are now working on ways to deliver inhibitors of mPGES-1 selectively to the macrophages.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/j41DL0TBLr4" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2014/04/140421151834.jpg" height="382" width="300" />
			<pubDate>Mon, 21 Apr 2014 15:18:34 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/04/140421151834.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/04/140421151834.htm</feedburner:origLink></item>
		<item>
			<title>Popular pain relievers may reduce risk of bladder cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/-9dV-gvHuH0/121107132918.htm</link>
			<description>Researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/-9dV-gvHuH0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 07 Nov 2012 13:29:18 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2012/11/121107132918.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2012/11/121107132918.htm</feedburner:origLink></item>
		<item>
			<title>NSAIDs and Cardiovascular Risk Explained</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/cGczmZ5uf4s/120502143846.htm</link>
			<description>After nearly 13 years of study and intense debate, a pair of new articles have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/cGczmZ5uf4s" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 May 2012 14:38:46 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2012/05/120502143846.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2012/05/120502143846.htm</feedburner:origLink></item>
		<item>
			<title>Study of COX-2 inhibitors could lead to new class of stroke drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/Vjkr041fZB0/111003131412.htm</link>
			<description>A new study in mice points toward potential new therapies for stroke, a leading cause of death and foremost single cause of severe neurological disability. The study also may reveal why a much-heralded class of blockbuster drugs failed to live up to their promise.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/Vjkr041fZB0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 03 Oct 2011 13:14:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2011/10/111003131412.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2011/10/111003131412.htm</feedburner:origLink></item>
		<item>
			<title>Separating a cancer prevention drug from heart disease risk</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/fLdvIV5ucY4/110913111410.htm</link>
			<description>Celecoxib reduces the risk of developing precancerous colon polyps, at the cost of increased heart disease risk. By looking closely at how celecoxib acts in the cell, it may be possible to get the benefit without the added risk. Celecoxib inhibits the enzyme GSK3, possibly accounting for its anticancer effects in multiple cell types.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/fLdvIV5ucY4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 13 Sep 2011 11:14:10 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2011/09/110913111410.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2011/09/110913111410.htm</feedburner:origLink></item>
		<item>
			<title>Why drugs increase risk of heart attacks and strokes: Analysis highlights cardiovascular risk of fluid retention</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/gzmfoc3nvE8/110222083511.htm</link>
			<description>New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the US Food and Drug Administration if the cardiovascular effects of fluid retention had been better understood.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/gzmfoc3nvE8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 22 Feb 2011 08:35:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2011/02/110222083511.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2011/02/110222083511.htm</feedburner:origLink></item>
		<item>
			<title>Common painkillers linked to increased risk of heart problems</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/5umfrX3YQIE/110111184132.htm</link>
			<description>Commonly used painkillers for treating inflammation can increase the risk of heart attacks and strokes, according to an analysis of the evidence.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/5umfrX3YQIE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 11 Jan 2011 18:41:32 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2011/01/110111184132.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2011/01/110111184132.htm</feedburner:origLink></item>
		<item>
			<title>Widely used arthritis pill protects against skin cancer, study suggests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/5XWL7OD86MU/101202124213.htm</link>
			<description>A widely used arthritis drug reduces the incidence of non-melanoma skin cancers -- the most common cancers in humans -- according to a new study. The COX-2 inhibitor celecoxib (Celebrex), which is approved for the treatment of arthritis and acute pain, led to a 62 percent reduction in non-melanoma skin cancers. In the future, a combination of medications that include sunscreens and COX inhibitors or other protective therapies may be used to decrease the incidence of skin cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/5XWL7OD86MU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 02 Dec 2010 12:42:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2010/12/101202124213.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2010/12/101202124213.htm</feedburner:origLink></item>
		<item>
			<title>Celecoxib (Celebrex) may be effective in preventing non-melanoma skin cancers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/FVlyfc5Ahy0/101129160948.htm</link>
			<description>Celecoxib (also known by its brand name Celebrex) may help prevent non-melanoma skin cancers in patients with extensive actinic keratosis, which is often a precursor to these cancers, according to a randomized clinical trial.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/FVlyfc5Ahy0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Nov 2010 16:09:48 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2010/11/101129160948.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2010/11/101129160948.htm</feedburner:origLink></item>
		<item>
			<title>Link between arthritis pain reliever and cardiovascular events discovered</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/qusBBb-a_ek/100913153632.htm</link>
			<description>Researchers have discovered a novel mechanism as to why the long-term, high-dosage use of the well-known arthritis pain medication, Vioxx, led to heart attacks and strokes. Their groundbreaking research may pave the way for a safer drug for millions of arthritis patients who suffer acute and chronic pain.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/qusBBb-a_ek" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 13 Sep 2010 15:36:32 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2010/09/100913153632.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2010/09/100913153632.htm</feedburner:origLink></item>
		<item>
			<title>Can Celebrex prevent cancer-causing colon polyps?</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/pjIAxg0B26Q/100513143538.htm</link>
			<description>Researchers are testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/pjIAxg0B26Q" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 13 May 2010 14:35:38 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2010/05/100513143538.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2010/05/100513143538.htm</feedburner:origLink></item>
		<item>
			<title>Painkiller undermines aspirin's anti-clotting action</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/X2F21rDL8-I/091214173750.htm</link>
			<description>Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/X2F21rDL8-I" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 14 Dec 2009 17:37:50 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2009/12/091214173750.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2009/12/091214173750.htm</feedburner:origLink></item>
		<item>
			<title>Vioxx trial data shows early cardiovascular risk</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/s4lP4U030Es/091123171412.htm</link>
			<description>Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck &amp; Co. Inc., voluntarily pulled the drug from the market.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/s4lP4U030Es" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 23 Nov 2009 17:14:12 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2009/11/091123171412.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2009/11/091123171412.htm</feedburner:origLink></item>
		<item>
			<title>Discovery In Colon Cancer Prevention</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/v7Dd-ji23aY/090518173315.htm</link>
			<description>A new study finds that individuals who have low expression of the "Celebrex gene," 15-PGDH, are actually resistant to Celebrex treatment when used to prevent colon cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/v7Dd-ji23aY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 18 May 2009 17:33:15 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2009/05/090518173315.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2009/05/090518173315.htm</feedburner:origLink></item>
		<item>
			<title>Potential Lung Disease Biomarkers Yield Clues To COX-2 Inhibitor Side Effects</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/4NAPrdPOXF0/090429172422.htm</link>
			<description>In searching for a simple way to identify individuals with smoking-related lung injury, scientists at have stumbled upon a potential explanation for why the class of pain-relievers known as COX-2 inhibitors increases the risk of heart problems among users.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/4NAPrdPOXF0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 29 Apr 2009 17:24:22 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2009/04/090429172422.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2009/04/090429172422.htm</feedburner:origLink></item>
		<item>
			<title>Prostaglandin Receptor Key To Atherosclerosis Development</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/Wlrosc8VFDw/081215140940.htm</link>
			<description>Atherosclerosis -- a disease that includes the buildup of fatty, cholesterol-laden lumps of cells inside the artery wall -- is the underlying cause of heart attacks and strokes. Researchers have now demonstrated that a receptor for prostaglandin-E2 plays a key role in the development of atherosclerosis. The findings point to this receptor and its signaling pathways as molecular targets for modulating atherosclerosis development.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/Wlrosc8VFDw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 15 Dec 2008 14:09:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2008/12/081215140940.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2008/12/081215140940.htm</feedburner:origLink></item>
		<item>
			<title>Prostate Cancer Can Be Halted With Anti-inflammatory And Statin Used In Tandem, Study Suggests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/a2spbgDAmN4/080414113215.htm</link>
			<description>Researchers have shown that administering a combination of the widely used drugs Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) and Lipitor (atorvastatin, a cholesterol lowering drug) stops the transition of early prostate cancer to its more aggressive and potentially fatal stage.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/a2spbgDAmN4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 14 Apr 2008 11:32:15 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2008/04/080414113215.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2008/04/080414113215.htm</feedburner:origLink></item>
		<item>
			<title>Potential New Drug Targets Against Hormone-dependent Breast Cancer Identified</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/tQb1Mh5-qtE/080228150351.htm</link>
			<description>The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to new, highly targeted therapies against the disease. The finding also helps explain how daily use of medicines such as aspirin might help keep these breast tumors at bay.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/tQb1Mh5-qtE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 28 Feb 2008 15:03:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2008/02/080228150351.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2008/02/080228150351.htm</feedburner:origLink></item>
		<item>
			<title>Popular Arthritis Drug May Disrupt Heart Rhythm, New Research Finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/FYDk-OXHKiE/080124161621.htm</link>
			<description>Celebrex, a popular arthritis drug that blocks pain by inhibiting an enzyme known as COX-2, has been shown in laboratory studies to induce arrhythmia, or irregular beating of the heart, via a novel pathway unrelated to its COX-2 inhibition.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/FYDk-OXHKiE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 24 Jan 2008 16:16:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2008/01/080124161621.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2008/01/080124161621.htm</feedburner:origLink></item>
		<item>
			<title>Celecoxib Can Adversely Affect Heart Rhythm, Study Suggests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/x43VqfWgI58/080114173854.htm</link>
			<description>COX-2 inhibitors like Celecoxib have come under scrutiny lately due to adverse cardiovascular side-effects stemming from COX-2 reduction. In both fruit fly and rat models, researchers reveal another adverse effect of Celecoxib; this drug can induce arrhythmia. More interestingly, this effect is independent of the COX-2 enzyme.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/x43VqfWgI58" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2008/01/080114173854.jpg" height="174" width="300" />
			<pubDate>Mon, 14 Jan 2008 17:38:54 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2008/01/080114173854.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2008/01/080114173854.htm</feedburner:origLink></item>
		<item>
			<title>Vioxx Side-effects: Possible Explanation</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/7LAyd0sEeKs/070827095231.htm</link>
			<description>Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. Scientists may now have figured out how these drugs trigger these life-threatening side-effects.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/7LAyd0sEeKs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 27 Aug 2007 09:52:31 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2007/08/070827095231.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2007/08/070827095231.htm</feedburner:origLink></item>
		<item>
			<title>Celecoxib Helps Prevent Restenosis And Appears Safe</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/gmACRTHwnIQ/070818102805.htm</link>
			<description>Adjunctive use of the COX-2 inhibitor celcoxib after stent implantation in patients with coronary artery disease appears safe and can reduce the need for revascularisation of the target lesion, conclude authors of a new article. But an accompanying comment warns that clinical trials suggest long-term use of celecoxib can expose patients to an additional risk of heart attack.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/gmACRTHwnIQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sat, 18 Aug 2007 10:28:05 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2007/08/070818102805.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2007/08/070818102805.htm</feedburner:origLink></item>
		<item>
			<title>Researcher Lays Out Benefits Of Aspirin To Prevent Colon Cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/c_9WNJY6yBU/070523181627.htm</link>
			<description>A colon cancer researcher has laid out in a recent article how he thinks medical science should employ aspirin and new aspirin-like drugs for use in preventing colon cancer in certain high-risk individuals.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/c_9WNJY6yBU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 23 May 2007 18:16:27 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2007/05/070523181627.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2007/05/070523181627.htm</feedburner:origLink></item>
		<item>
			<title>Combining NSAIDs With Chemotherapy, Radiation May Improve Cancer Treatment</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/KtFIuu7DriU/070517101745.htm</link>
			<description>Certain nonsteroidal anti-inflammatory drugs may be better suited to treating cancer, in combination with standard therapies, rather than preventing it, according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/KtFIuu7DriU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 May 2007 10:17:45 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2007/05/070517101745.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2007/05/070517101745.htm</feedburner:origLink></item>
		<item>
			<title>FDA Causes Unnecessary Scare About Common Painkillers, Says Doctor</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/v26U5q31PyY/070424155532.htm</link>
			<description>The US Food and Drug Administration has caused an unnecessary scare about some pain relievers by adding a warning to drugs that are safe, says Curt Furberg, M.D., Ph.D., from Wake Forest University School of Medicine. At the same time, he says the agency has failed to recognize the harm of a pain reliever that should be taken off the market.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/v26U5q31PyY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 24 Apr 2007 15:55:32 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2007/04/070424155532.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2007/04/070424155532.htm</feedburner:origLink></item>
		<item>
			<title>Green Tea And COX-2 Inhibitors Combine To Slow Growth Of Prostate Cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/DvsK3iR2BdY/070301081810.htm</link>
			<description>Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/DvsK3iR2BdY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 01 Mar 2007 08:18:10 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2007/03/070301081810.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2007/03/070301081810.htm</feedburner:origLink></item>
		<item>
			<title>Engineering The 'Super Enzyme' -- A Potential New Weapon Against Heart Disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/zQCvxQzUISs/061128084827.htm</link>
			<description>Efforts to understand the link between the cyclooxygenase-2 (COX-2) inhibitor arthritis drugs and heart disease have had an unanticipated benefit in leading to development of an engineered protein with "great potential" as a new treatment for heart disease, according to a new scientific report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/zQCvxQzUISs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 28 Nov 2006 08:48:27 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/11/061128084827.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/11/061128084827.htm</feedburner:origLink></item>
		<item>
			<title>Celecoxib, Naproxen Safety Results Now Published</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/86DRfGaiKS4/061120060431.htm</link>
			<description>A paper appearing this week in the Public Library of Science journal PLoS Clinical Trials presents findings from a large National Institutes of Health sponsored trial regarding the cardiovascular and cerebrovascular safety of two non-steroidal anti-inflammatory drugs, celecoxib and naproxen.  The trial was initially conducted to test whether these drugs might prevent or delay the onset of Alzheimer's disease.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/86DRfGaiKS4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 20 Nov 2006 06:04:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/11/061120060431.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/11/061120060431.htm</feedburner:origLink></item>
		<item>
			<title>Doctors Develop New Approach To Web-based Drug Withdrawal Warnings</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/ZTVbzg5UOiw/060925113458.htm</link>
			<description>The University of Cincinnati has developed a faster approach for informing consumers online when the Food and Drug Administration (FDA) withdraws a medication. Researchers hope this new 24-hour update method will become the standard response system for Web sites carrying critical consumer health information.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/ZTVbzg5UOiw" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2006/09/060925113458.jpg" height="189" width="300" />
			<pubDate>Mon, 25 Sep 2006 11:34:58 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/09/060925113458.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/09/060925113458.htm</feedburner:origLink></item>
		<item>
			<title>New Evidence On Risks Associated With Cox-2 Inhibitors And NSAIDs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/aOl_hfPumm0/060915203524.htm</link>
			<description>Two new review studies evaluating the safety of the pain-relieving medications selective cyclooxygenase 2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) find increased cardiovascular and kidney risks.  The studies and an accompanying editorial were posted online today by JAMA because of the public health implications of the findings.  The articles will appear in the October 4 print issue of JAMA.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/aOl_hfPumm0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 15 Sep 2006 20:35:24 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/09/060915203524.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/09/060915203524.htm</feedburner:origLink></item>
		<item>
			<title>New Type Of Pain Reliever May Benefit The Heart</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/d86oPN7xMIE/060912230236.htm</link>
			<description>Researchers at the University of Pennsylvania School of Medicine have found that deleting an inflammation enzyme in a mouse model of heart disease slowed the development of atherosclerosis. What's more, the composition of the animals' blood vessels showed that the disease process had not only slowed, but also stabilized. This study points to the possibility of a new class of nonsteroidal anti-inflammatory drugs that steer clear of heart-disease risk and work to reduce it.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/d86oPN7xMIE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 12 Sep 2006 23:02:36 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/09/060912230236.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/09/060912230236.htm</feedburner:origLink></item>
		<item>
			<title>New Celebrex Study: Unlocking Colon Cancer With Key Of Prevention</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/1GqKWAYDTUs/060830220508.htm</link>
			<description>An international team of scientists reports that a single 400-milligram daily dose of celecoxib, commonly called Celebrex and manufactured by Pfizer, significantly reduced recurrence of adenomas -- or pre-malignant colon tumors -- within three years of previous adenoma removal.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/1GqKWAYDTUs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 30 Aug 2006 22:05:08 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/08/060830220508.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/08/060830220508.htm</feedburner:origLink></item>
		<item>
			<title>Study Finds That Vioxx Reduces The Risk Of Colorectal Polyps</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/7SOLUffe4Xo/060830215121.htm</link>
			<description>A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 inhibitor rofecoxib reduces the risk of colorectal adenomas, or polyps.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/7SOLUffe4Xo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 30 Aug 2006 21:51:21 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/08/060830215121.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/08/060830215121.htm</feedburner:origLink></item>
		<item>
			<title>Pest Control Research Leads To Pain Control Discovery</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/7MoMj3zcjRw/060828211618.htm</link>
			<description>A newly discovered enzyme inhibitor, identified by researchers originally looking for biological pest controls, may lead to pain relief for sufferers of arthritis and other inflammatory diseases, say researchers at the University of California, Davis. The finding, hailed by a noted inflammatory disease expert "as the most important discovery in inflammation in more than a decade," may also reduce side effects associated with the painkiller, Vioxx.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/7MoMj3zcjRw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 28 Aug 2006 21:16:18 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/08/060828211618.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/08/060828211618.htm</feedburner:origLink></item>
		<item>
			<title>New Study Re-evaluates Cardiovascular Risks Of Anti-inflammatory Drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/sj91YZa1low/060602074341.htm</link>
			<description>High doses of some traditional non-steroidal anti-inflammatory drugs (NSAIDS) are associated with similar cardiovascular risks as the new generation of anti-inflammatory drugs known as COX 2 inhibitors (like Vioxx), finds a study in this week's British Medical Journal.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/sj91YZa1low" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 02 Jun 2006 07:43:41 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/06/060602074341.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/06/060602074341.htm</feedburner:origLink></item>
		<item>
			<title>New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/AkaHsD4jnN8/060529102245.htm</link>
			<description>COX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and Vioxx in a more complex manner than was previously understood, a Queen's University study has found.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/AkaHsD4jnN8" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2006/05/060529102245.jpg" height="199" width="300" />
			<pubDate>Mon, 29 May 2006 10:22:45 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/05/060529102245.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/05/060529102245.htm</feedburner:origLink></item>
		<item>
			<title>Heart Risks From Vioxx Happen Much Earlier Than Believed</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/pou4NcNf6tM/060504081246.htm</link>
			<description>A new study led by Queen's University researcher Linda LÃ©vesque shows that heart attacks related to the use of Vioxx -- a drug once popular for the treatment of pain and inflammation -- can occur within the first two weeks of use.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/pou4NcNf6tM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 04 May 2006 08:12:46 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/05/060504081246.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/05/060504081246.htm</feedburner:origLink></item>
		<item>
			<title>Study Reveals Vioxx Related Heart Attacks Can Occur Within The First Two Weeks Of Use</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/OLFzOAHbUUY/060502172943.htm</link>
			<description>A quarter of patients who suffered a heart attack while taking Vioxx did so within the first two weeks of taking the drug, a new study published by MUHC investigators reveals. The research, scheduled for early online publication in the Canadian Medical Association Journal (CMAJ) today, demonstrates that cardiovascular risks from taking Vioxx may occur much earlier than previously believed.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/OLFzOAHbUUY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 02 May 2006 17:29:43 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/05/060502172943.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/05/060502172943.htm</feedburner:origLink></item>
		<item>
			<title>Study Points Toward Alternatives For Vioxx And Celebrex</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/1OGnhsb2EWI/060417124231.htm</link>
			<description>Researchers at Queen's University and the University of Pennsylvania 
have identified one reason why drugs like Celebrex and Vioxx -- once popular for the treatment of pain and inflammation -- cause heart problems.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/1OGnhsb2EWI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 17 Apr 2006 12:42:31 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/04/060417124231.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/04/060417124231.htm</feedburner:origLink></item>
		<item>
			<title>Penn Study Suggests New Class Of Anti-inflammatory Drugs That Might Lessen Chance Of COX-2 Cardiovascular Problems</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/X8in4Gxo1XM/060415115521.htm</link>
			<description>Researchers at the University of Pennsylvania School of Medicine have clarified the mechanism by which drugs like Celebrex and Vioxx cause heart problems, in multiple animal models. The findings offer the prospect of a new generation of anti-inflammatory drugs that bypass this issue.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/X8in4Gxo1XM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sat, 15 Apr 2006 11:55:21 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/04/060415115521.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/04/060415115521.htm</feedburner:origLink></item>
		<item>
			<title>COX-2 Inhibitors Significantly Reduce Risk Of Cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/mMTucd-NPCQ/060403130703.htm</link>
			<description>Results from a new, five-year study show that regular use of popular prescription pain relievers may reduce the risk of breast cancer by up to 71 percent and may offer similar benefit in the prevention of prostate, colon and lung cancers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/mMTucd-NPCQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 03 Apr 2006 13:07:03 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/04/060403130703.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/04/060403130703.htm</feedburner:origLink></item>
		<item>
			<title>Regular Use Of Selective COX-2 Inhibitors Decreases Risk Of Breast Cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/8CcyahYAGEs/060130032351.htm</link>
			<description>Regular use of selective COX-2 inhibitors significantly reduces the risk of breast cancer. A case-control study published today in the open access journal BMC Cancer observed that daily use of selective COX-2 inhibitors, including celecoxib (Celebrex) and rofecoxib (Vioxx), was associated with a 71 percent reduction in the risk of breast cancer. Non-selective COX-2 inhibitors, such as aspirin and ibuprofen, also reduced the risk of breast cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/8CcyahYAGEs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 30 Jan 2006 03:23:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/01/060130032351.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/01/060130032351.htm</feedburner:origLink></item>
		<item>
			<title>'Vioxx Like' Drugs May Still Be Best Option For Arthritis, Write Scientists</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/gBTpCoHpVGs/060118214940.htm</link>
			<description>Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/gBTpCoHpVGs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 18 Jan 2006 21:49:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/01/060118214940.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/01/060118214940.htm</feedburner:origLink></item>
		<item>
			<title>Variation In Genetic Make-up Determines Each Person's Reaction To Popular Painkillers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/XUK2lXdHOwc/060105085659.htm</link>
			<description>A study published in the January issue of the American Gastroenterological Association (AGA) journal Gastroenterology found a difference in how people responded to popular painkillers and that up to 30 percent of this variability can be attributed to an individual's genetic make-up.  This variation can influence both how useful the drugs are in affording relief from pain and inflammation, and the number and severity of the adverse effects.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/XUK2lXdHOwc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 05 Jan 2006 08:56:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2006/01/060105085659.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2006/01/060105085659.htm</feedburner:origLink></item>
		<item>
			<title>Most NSAIDs Raise Risk Of Death After Heart Attack</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/_wtYYoSfL-0/051114112914.htm</link>
			<description>Taking either COX-2 inhibitors or other non-steroidal anti-inflammatory drugs (NSAIDs) after a heart attack, especially in high doses, increases the risk of death, researchers reported at the American Heart Association's Scientific Sessions 2005.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/_wtYYoSfL-0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 14 Nov 2005 11:29:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/11/051114112914.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/11/051114112914.htm</feedburner:origLink></item>
		<item>
			<title>Aspirin Might Prevent Vioxx Cardiac Damage</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/ZUMhczv_bL0/050914105945.htm</link>
			<description>Low-dose aspirin might prevent the cardiovascular damage known to arise from use of the painkiller rofecoxib (VioxxÂ®), suggest new findings from mouse studies by Duke University Medical Center researchers. Their findings that a chemical imbalance might underlie such damage could also lead to the development of anti-inflammatory drugs without the adverse side effects, the researchers said.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/ZUMhczv_bL0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 14 Sep 2005 10:59:45 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/09/050914105945.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/09/050914105945.htm</feedburner:origLink></item>
		<item>
			<title>Long-term Aspirin Use May Incur Risk</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/eKrc1Sg7too/050603061648.htm</link>
			<description>Women who take ibuprofen or aspirin daily for several years might face a higher risk of certain breast cancers, according to preventive medicine researchers in the Keck School of Medicine of the University of Southern California.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/eKrc1Sg7too" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 03 Jun 2005 06:16:48 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/06/050603061648.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/06/050603061648.htm</feedburner:origLink></item>
		<item>
			<title>Penn Study Points To How COX-2 Inhibitors Can Eventually Lead To Heart Disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/9-axBkq00H0/050525110001.htm</link>
			<description>University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and stroke. In Circulation Research, they report that a COX-2-derived fatty substance -- a prostaglandin called prostacyclin -- controls the blood-vessel response to stresses such as high-blood pressure, thereby further linking COX-2 inhibitors to an increased risk of heart attack or stroke.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/9-axBkq00H0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 25 May 2005 11:00:01 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/05/050525110001.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/05/050525110001.htm</feedburner:origLink></item>
		<item>
			<title>Two Drugs Combined More Cost-effective Safer For Managing Arthritis In High-risk Patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/eD6CI9xmuT8/050509102110.htm</link>
			<description>A new UCLA study shows that for arthritis sufferers at high-risk for gastrointestinal problems, the most cost-effective safer treatment is a common painkiller combined with an acid-reducing drug.  The study, completed over a year ago, compares three competing therapies for chronic arthritis and shows that this drug combination was more cost-effective and safer than Cox-2 inhibitors.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/eD6CI9xmuT8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 09 May 2005 10:21:10 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/05/050509102110.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/05/050509102110.htm</feedburner:origLink></item>
		<item>
			<title>FDA Announces Series Of Changes To The Class Of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/gdxA_7Qttss/050419111857.htm</link>
			<description>The Food and Drug Administration (FDA) has announced a series of important changes pertaining to the marketing of the non-steroidal anti-inflammatory class of drugs, including COX-2 selective and prescription and non-prescription (over-the-counter (OTC)) non-selective NSAID medications.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/gdxA_7Qttss" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 19 Apr 2005 11:18:57 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/04/050419111857.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/04/050419111857.htm</feedburner:origLink></item>
		<item>
			<title>Study Shows Common Painkillers Combined With Acid-Reducing Drugs More Cost-Effective, Safer For Managing Arthritis In High-Risk Patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/Kpe_xUpUyyg/050411211308.htm</link>
			<description>Amid the recent controversy and confusion over serious side effects from pain medications, a new UCLA and Veterans Affairs Greater Los Angeles Healthcare System study demonstrates that for arthritis sufferers at high risk for gastrointestinal problems who traditionally may have used a drug like Vioxx, the most cost-effective and safest treatment is actually a common painkiller combined with an acid-reducing drug.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/Kpe_xUpUyyg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 11 Apr 2005 21:13:08 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/04/050411211308.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/04/050411211308.htm</feedburner:origLink></item>
		<item>
			<title>Celebrex Provides A Two Pronged Attack Against Prostate Cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/tfCh3-f0i3g/050309104538.htm</link>
			<description>Celecoxib, a selective COX-2 inhibitor with promising anti-cancer properties, has now been found to attack prostate cancer cells in a second way that differs from Vioxx (rofecoxib), another anti-inflammatory drug that also inhibits COX-2.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/tfCh3-f0i3g" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 09 Mar 2005 10:45:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/03/050309104538.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/03/050309104538.htm</feedburner:origLink></item>
		<item>
			<title>COX-2 Inhibitors Associated With Blood Pressure Elevation</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/UC0pMitNNzk/050218132538.htm</link>
			<description>An analysis of 19 randomized controlled trials involving COX-2 inhibitors (selective cyclooxygenase-2 inhibitors) suggests that these agents raise blood pressure more than either conventional nonsteroidal anti-inflammatory drugs (NSAIDs) or placebo, according to a study to be published in an upcoming issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/UC0pMitNNzk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 18 Feb 2005 13:25:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/02/050218132538.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/02/050218132538.htm</feedburner:origLink></item>
		<item>
			<title>Researchers Confirm Vioxx Nearly Doubled Cardiovascular Risks In Cancer Prevention Study</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/xFzZp-hWW1E/050218131255.htm</link>
			<description>The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular âeventâ ââ heart attacks and/or strokes ââ was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 online in The New England Journal of Medicine.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/xFzZp-hWW1E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 18 Feb 2005 13:12:55 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/02/050218131255.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/02/050218131255.htm</feedburner:origLink></item>
		<item>
			<title>COX-2 Product Offers Good And Bad News In 'Test Tube' Strokes</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/5JPAK08fflM/050217224933.htm</link>
			<description>Laboratory studies at Johns Hopkins have revealed that certain products of the enzymes COX-1 and COX-2 can both protect and damage the brain. The findings, published in the February 2005 issue of the Journal of Neurochemistry, offer tantalizing clues to why drugs like Vioxx and Celebrex, which block COX-2, can ease arthritis but potentially harm the heart and brain.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/5JPAK08fflM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 Feb 2005 22:49:33 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/02/050217224933.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/02/050217224933.htm</feedburner:origLink></item>
		<item>
			<title>COX-2 Inhibitor Increases The Risk Of Heart Attack In Elderly Adults With No History Of Heart Attack</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/vioxx/~3/LIVhy9oV3-c/050205122443.htm</link>
			<description>New research published in the on-line version of the Annals of Internal Medicine today, documents an increased risk of heart attack with one of the COX-2 inhibitors used in elderly adults with no previous history of heart attack--a group previously considered low-risk.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/vioxx/~4/LIVhy9oV3-c" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sat, 05 Feb 2005 12:24:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2005/02/050205122443.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2005/02/050205122443.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 23:07:01 EST -->
